Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-82086 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-82086, RRID:AB_1144568
- Product name
- Rabbit Polyclonal RelA/NFkB p65 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. NkappaF-B p65 (specific to Phospho-Ser276) detects endogenous levels of NF-B p65 only when phosphorylated at serine 276.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.05 ml
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Ye J, Guan M, Lu Y, Zhang D, Li C, Li Y, Zhou C
European journal of pharmacology 2019 Jun 5;852:151-158
European journal of pharmacology 2019 Jun 5;852:151-158
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S, Moore TW, Morii N, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M
Current cancer drug targets 2014;14(4):380-93
Current cancer drug targets 2014;14(4):380-93
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S, Moore TW, Morii N, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M
Current cancer drug targets 2014;14(4):380-93
Current cancer drug targets 2014;14(4):380-93
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S, Moore TW, Lin X, Morii N, Mancini A, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M
Integrative biology : quantitative biosciences from nano to macro 2012 Jun;4(6):633-40
Integrative biology : quantitative biosciences from nano to macro 2012 Jun;4(6):633-40
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Analysis of extract from HeLa cells using NF-kB p65 (phospho-Ser276) antibody NB100-82086
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Analysis of paraffin- embedded human breast carcinoma tissue using NF-kB p65 (phospho-Ser276) antibody NB100-82086.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Human breast carcinoma tissue.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: RelA/NFkB p65 [p Ser276] Antibody [NB100-82086] - Human lung carcinoma tissue.